157 related articles for article (PubMed ID: 36303202)
1. Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes.
Ueno M; Miyagawa I; Miyazaki Y; Hanami K; Fukuyo S; Kubo S; Nakayamada S; Tanaka Y
Arthritis Res Ther; 2022 Oct; 24(1):240. PubMed ID: 36303202
[TBL] [Abstract][Full Text] [Related]
2. Guselkumab improves joint pain in patients with pustulotic arthro-osteitis: A retrospective pilot study.
Ikumi N; Fujita H; Terui T
J Dermatol; 2021 Feb; 48(2):199-202. PubMed ID: 33051886
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of guselkumab in a subpopulation with pustulotic arthro-osteitis through week 52: an exploratory analysis of a phase 3, randomized, double-blind, placebo-controlled study in Japanese patients with palmoplantar pustulosis.
Yamamoto T; Fukuda K; Morita A; Kimura T; Morishima H; Goto R; Zheng R; Terui T
J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):2318-2329. PubMed ID: 32173916
[TBL] [Abstract][Full Text] [Related]
4. Correction: Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes.
Ueno M; Miyagawa I; Miyazaki Y; Hanami K; Fukuyo S; Kubo S; Nakayamada S; Tanaka Y
Arthritis Res Ther; 2023 Feb; 25(1):24. PubMed ID: 36788609
[No Abstract] [Full Text] [Related]
5. Utility of nailfold capillary assessment for predicting pustulotic arthro-osteitis in palmoplantar pustulosis based on a prospective cohort study.
Fukasawa T; Yamashita T; Enomoto A; Toyama S; Yoshizaki-Ogawa A; Tateishi S; Kanda H; Miyagawa K; Sato S; Yoshizaki A
J Am Acad Dermatol; 2023 Nov; 89(5):984-991. PubMed ID: 37517674
[TBL] [Abstract][Full Text] [Related]
6. Palmoplantar pustulosis and pustulotic arthro-osteitis associated with multiple venous occlusion: A case report and literature review.
Inoue E; Hiroumi S; Sato S; Hayashi M; Konaka H; Tsuji S; Higashiyama M
J Dermatol; 2023 Aug; 50(8):1076-1080. PubMed ID: 37017424
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy of granulocyte and monocyte adsorption apheresis on skin manifestation and joint symptoms of patients with pustulotic arthro-osteitis.
Kawakami H; Nagaoka Y; Hirano H; Matsumoto Y; Abe N; Tsuboi R; Kanno Y; Okubo Y
J Dermatol; 2019 Feb; 46(2):144-148. PubMed ID: 30549087
[TBL] [Abstract][Full Text] [Related]
8. Non-bacterial vertebral osteitis as the first manifestation of pustulotic arthro-osteitis.
Ueda Y; Yokogawa N; Shimada K
Mod Rheumatol Case Rep; 2023 Jun; 7(2):488-490. PubMed ID: 36905395
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of pustulotic arthro-osteitis in Korea.
Kim M; Kim M; Kim JW; Kim BR; Youn SW
J Dermatol; 2022 Aug; 49(8):762-768. PubMed ID: 35510638
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and treatment status of pustulotic arthro-osteitis: A single-center study involving 51 cases.
Kondo N; Sakai Y; Kakutani R; Netsu T; Kijima Y; Kudo N; Endo N; Kawashima H
J Dermatol; 2021 Nov; 48(11):1724-1730. PubMed ID: 34368990
[TBL] [Abstract][Full Text] [Related]
11. Effects of guselkumab on ankylosing spondylitis-type pustulotic arthro-osteitis in a patient with palmoplantar pustulosis.
Yamamoto T
Dermatol Ther; 2020 Nov; 33(6):e14088. PubMed ID: 33439526
[No Abstract] [Full Text] [Related]
12. Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective.
Yamamoto T
Clin Pharmacol; 2021; 13():135-143. PubMed ID: 34188558
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcome and prognostic factors of tonsillectomy for palmoplantar pustulosis and pustulotic arthro-osteitis: A retrospective subjective and objective quantitative analysis of 138 patients.
Takahara M; Hirata Y; Nagato T; Kishibe K; Katada A; Hayashi T; Kishibe M; Ishida-Yamamoto A; Harabuchi Y
J Dermatol; 2018 Jul; 45(7):812-823. PubMed ID: 29732605
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of pustulotic arthro-osteitis with amoxicillin: A case report and review of the literature.
Terui H; Segawa Y; Otake E; Omori R; Tsuchiyama K; Kikuchi K; Yamasaki K; Aiba S; Asano Y
J Dermatol; 2023 Nov; 50(11):1478-1483. PubMed ID: 37269150
[TBL] [Abstract][Full Text] [Related]
15. Nail lesions in palmoplantar pustulosis and pustulotic arthro-osteitis impairs patients' quality of life: Suggesting new assessment tool of PPP nail lesions.
Masuda-Kuroki K; Kawakami H; Abe N; Mori M; Tobita R; Fukushi R; Hiruma J; Takeda Y; Okubo Y
J Dermatol Sci; 2022 Apr; 106(1):29-36. PubMed ID: 35307234
[TBL] [Abstract][Full Text] [Related]
16. Use of biologics for pustulotic arthro-osteitis in two patients with palmoplantar pustulosis.
Ohashi T; Suzuki Y; Yamamoto T
J Dermatol; 2017 Jan; 44(1):97-98. PubMed ID: 27162198
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator-controlled VOYAGE 1 trial.
Blauvelt A; Papp KA; Griffiths CE; Randazzo B; Wasfi Y; Shen YK; Li S; Kimball AB
J Am Acad Dermatol; 2017 Mar; 76(3):405-417. PubMed ID: 28057360
[TBL] [Abstract][Full Text] [Related]
18. Pustulotic Arthro-Osteitis (Sonozaki Syndrome): A Case Report and Review of Literature.
Kose R; Senturk T; Sargin G; Cildag S; Kara Y
Eurasian J Med; 2018 Feb; 50(1):53-55. PubMed ID: 29531495
[TBL] [Abstract][Full Text] [Related]
19. Pustulotic arthro-osteitis associated with palmoplantar pustulosis.
Yamamoto T
J Dermatol; 2013 Nov; 40(11):857-63. PubMed ID: 24127744
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator-controlled VOYAGE 2 trial.
Reich K; Armstrong AW; Foley P; Song M; Wasfi Y; Randazzo B; Li S; Shen YK; Gordon KB
J Am Acad Dermatol; 2017 Mar; 76(3):418-431. PubMed ID: 28057361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
